Publications

5813 Results

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

Authors
C Presant;R Vaidya;C Till;K Ashing;G Warren;D Hershman;V Sun;R Salgia;E Massarelli;J Mortimer;G Idos;S Pal;T Dorff;A Amini;L Erhunmwunsee;T Phillips;A Johnson;B Adesunloye;F Bedell;A Tergas;I Amanam;S Rosen;J Unger
Journal / Conference
Cancer Jan 1;131(1):e35560
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID39283236
PMC
PMC11834169

Intake and Nutritional Adequacy in Cancer Patients Diagnosed with Malignant Bowel Obstruction: A secondary analysis of a randomized trial

Authors
C Thomson;K Arnold;G Anderson;V Sun;A Secord;A Yung;M Al-Kaspooles;V Nfonsam;M Grant;G Deutsch;J Deneve;R Krouse
Journal / Conference
Journal of the Academy of Nutrition and Dietetics May;125(5):654-665.e3
Year
2025
Research Committee(s)
Palliative Care
PMID
PMID39603592
PMC
PMCIDPMC12009688
Study Number(s)
S1316

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Vulvar Cancers

Authors
Y Chae;L Corthell;S Patel;R Edwards;J Scalici;H Kim;L Il-Young Chung;M Othus;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
Clinical Cancer Research Jan 17;31(2):308-315
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39561273
PMC
PMC11804806
Study Number(s)
S1609

Correlation of body mass index with overall survival in patients with metastatic hormone-sensitive prostate cancer: Analysis of patient-level data from SWOG-1216 study

Authors
U Swami;Y Jo;A Narang;M Plets;C Chehade;G Gebrael;S Gupta;Z Myint;C Tangen;P Lara;I Thompson;M Hussain;T Dorff;S Lerner;N Agarwal
Journal / Conference
European Urology Oncology Jun;8(3):612-615
Year
2025
Research Committee(s)
Genitourinary
PMID
PMID39521639
PMC
PMC12059143
Study Number(s)
S1216

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers (SWOG S1815; NCT#03768414)

Authors
R Shroff;G King;S Colby;A Scott;M Borad;K Matin;A Mahipal;A Kalyan;M Javle;I El Dika;B Tan;P Cheema;A Patel;R Iyer;R Kelley;J Thumar;A El-Khoueiry;K Guthrie;EG Chiorean;H Hochster;P Philip
Journal / Conference
Journal of Clinical Oncology Feb 10;43(5):536-544
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID39671534
PMC
PMC11798714
Study Number(s)
S1815

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive BC in the Phase III RxPONDER Trial (SWOG S1007)

Authors
Y Abdou;W Barlow;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;A Schott;S Shak;P Sharma;D Lew;J Miao;J Unger;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
JNCI-Journal of the National Cancer Institute May 1;117(5):889-897
Year
2025
Research Committee(s)
Breast
PMID
PMID39656951
PMC
PMC12058262
Study Number(s)
S1007

Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929

Authors
N Abdel Karim;J Miao;K Reckamp;C Gay;L Byers;Y Zhao;M Redman;D Carrizosa;W Wang;W Petty;K Mehta;B Faller;E Agamah;S Kasbari;R Malisetti;A Kumar;J Schallenkamp;K Alluri;J Gray;K Kelly
Journal / Conference
Journal of Thoracic Oncology Mar;20(3):383-394
Year
2025
Research Committee(s)
Lung
PMID
PMID39505259
Study Number(s)
S1929

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patient with RAS/BRAF wild-type, HER2-positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase 2 Trial

Authors
K Raghav;K Guthrie;B Tan;C Denlinger;M Fakih;M Overman;NA Dasari;L Corum;L Hicks;M Patel;B Esparaz;S Kazmi;N Alluri;S Colby;S Gholami;P Gold;EG Chiorean;ES Kopetz;H Hochster;PA Philip
Journal / Conference
Journal of Clinical Oncology Apr 10;43(11):1348-1357
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID39761503
PMC
PMC11975499
Study Number(s)
S1613

Evaluating the impact of stratification on the power and cross-arm balance of randomized Phase 2 clinical trials

Authors
A Moseley;M LeBlanc;B Freidlin;R Shallis;A Zeidan;D Sallman;H Erba;R Little;M Othus
Journal / Conference
Clinical Trials 2025 Jun;22(3):361-366. doi: 10.1177/17407745241304065. Epub 2025 Jan 15.
Year
2025
Research Committee(s)
Leukemia
Study Number(s)
MYELOMATCH

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study

Authors
S El Kababji;N Mitsakakis;E Jonker;A Beltran-Bless;G Pond;L Vandermeer;D Radhakrishnan;L Mosquera;A Paterson;L Shepherd;B Chen;W Barlow;J Gralow;M Savard;C Fesl;D Hlauschek;M Balic;G Rinnerthaler;R Greil;M Gnant;M Clemons;K El Emam;B Eng
Journal / Conference
Journal of Medical Internet Research vol. 27 | e66821
Year
2025
Research Committee(s)
Breast
PMID
40053790
Study Number(s)
S0307